{"filings":[{"id":1230888,"accession_number":"0001493152-26-029837","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-06-23T22:03:08+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Selectis Health to be acquired by Black Pearl for $5.75 per share in cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Selectis Health stockholders to receive $5.75 per share in cash in acquisition by Black Pearl Equities affiliates.","Transaction expected to close in Q3 2026, subject to 70% minimum tender condition, regulatory approvals, and customary conditions.","No financing contingency: Purchaser has committed funds for the Offer and Merger.","Board unanimously approved the merger; certain stockholders agreed to tender their shares under a Tender and Support Agreement.","Termination fee of $400,000 payable by Selectis if it accepts a superior proposal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":552236,"accession_number":"0001493152-26-024584","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-05-20T19:13:47+00:00","items":["5.02","9.01"],"status":"ready","headline":"CEO/CFO Adam Desmond resigns; Krystal Eckhart appointed interim CEO and CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Adam Desmond resigned as CEO, CFO, and board member effective May 14, 2026.","Separation Agreement and Release signed (Exhibit 10.1).","Krystal Eckhart, age 41, former VP of Revenue Management, appointed Interim CEO and CFO effective May 15, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98536,"accession_number":"0001493152-26-021783","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Selectis Health sells two Georgia SNFs for $15.7M; net proceeds ~$9M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sold Glen Eagle Healthcare (101-bed, Abbeville) and Eastman Healthcare (100-bed) to GA SNF entities.","Aggregate purchase price $15.7M; net proceeds after mortgage debt and liabilities ~$9M.","Additional $1.57M held in escrow; may be released to Sellers absent indemnity claims.","Sellers retain right to collect pre-closing tenant receivables, including deferred amounts.","Operations transferred to Purchaser's subsidiaries concurrently; no extra consideration paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114082,"accession_number":"0001493152-26-014113","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health board member David Furstenberg resigns effective March 30, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David Furstenberg resigned from the Board of Directors and Audit Committee on March 30, 2026.","Resignation is effective immediately; no reason given in the filing.","Company thanked Furstenberg for his service and support."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114081,"accession_number":"0001493152-26-011364","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-03-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health appoints Richard Huebner to Board of Directors effective March 12, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Richard Huebner, age 68, appointed to Selectis Health Board effective March 12, 2026.","He is senior managing partner and investment banker at GVC Capital LLC since 2001.","Compensation: $30,000 annual stipend under the Outside Directors Compensation Plan.","Previously served as EVP at Fiserv Correspondent Services (1984-2000) and roles at Hanifen Imhoff.","Holds BA from Hastings College and JD from University of Nebraska."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114080,"accession_number":"0001493152-26-009320","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-03-09T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Selectis Health agrees to sell two Georgia skilled nursing facilities for $15.7M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $15.7M for Glen Eagle (101-bed) and Eastman (100-bed) facilities in Georgia.","Closing expected around June 1, 2026, subject to due diligence and regulatory approvals.","Due diligence period ends April 22, 2026; $314K total deposit required.","Operations transfer agreement signed with buyer affiliates for facility management.","No assurance transaction will close; stock not listed on national exchange."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114079,"accession_number":"0001493152-26-003131","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-01-21T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Selectis Health sells two Georgia skilled nursing facilities for $13.175 million","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sold Sparta (71-bed) and Warrenton (110-bed) facilities for aggregate $13.175M; escrow of $1.3M.","Net cash proceeds ~$12.8M used to repay mortgage ($5.8M), other debt, transaction costs; balance for working capital.","Pro forma net loss attributable to common: $(654)K for nine months Sep 30, 2025 (vs historical $(242)K); $(1.79)M for FY 2024 (vs $(2.45)M).","Pro forma total assets $34.5M, debt reduced to $24.5M from $30.3M; stockholders' equity becomes positive $3.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114078,"accession_number":"0001493152-26-000558","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health appoints Kent Lund and Lance Baller to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Effective January 1, 2026, Board appointed Kent Lund, age 70, with legal/securities background and former FINRA committee member.","Board also appointed Lance Baller, age 51, co-founder of Iofina and former CEO of Selectis Health (2015-2023).","Baller brings experience in corporate finance, M&A, and governance; currently serves on boards of several funds and districts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130469,"accession_number":"0001493152-25-029572","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2025-12-30T23:59:59+00:00","items":["2.03","3.03","9.01"],"status":"ready","headline":"Selectis Health extends $1.775M notes to Feb 2026, interest rate raised to 13%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Maturity extended to Feb 28, 2026 or earlier upon Qualified Transaction; 30-day extensions possible with 0.5% fee.","Interest rate increased from 11% to 13% per annum effective Jan 1, 2026.","Warrants extended to Dec 31, 2027; exercise price unchanged at $2.25 per share.","Kent Lund and Lance Baller appointed to Board of Directors effective Jan 1, 2026.","Solicitation fee of $9,000 paid to GVC Capital LLC in connection with the amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130468,"accession_number":"0001493152-25-026960","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Selectis Health agrees to sell two Georgia skilled nursing facilities for $13.175M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total purchase price $13,175,000 for 71-bed Sparta and 110-bed Warrenton facilities.","Sale contingent on due diligence and other customary conditions; no assurance of closing.","Concurrent Operations Transfer Agreement governs transition of operations to purchasers' affiliates.","Sellers are wholly-owned subsidiaries Providence HR, LLC and Atl/Warr, LLC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147029,"accession_number":"0001641172-25-019912","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2025-07-16T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Purchaser terminates PSA and OTA for Selectis Health's Georgia subsidiaries; company to pursue remedies","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchaser terminated the Purchase and Sale Agreement and Operations Transfer Agreement for Georgia subsidiaries effective July 13, 2025.","Company received written notice from Purchaser on July 13, 2025 that the PSA and OTA were terminated without consummation.","Company intends to pursue all rights and remedies in the matter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165554,"accession_number":"0001641172-25-015818","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Selectis Health's common stock approved for OTCQB quotation effective June 23","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received OTC Markets approval for upgraded quotation on the OTCQB tier.","Trading under symbol 'GBCS' will commence at market open on June 23, 2025.","Notification occurred on June 20, 2025; no financial details disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183180,"accession_number":"0001493152-25-006371","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2025-02-13T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Selectis Health signs $27M deal to sell four Georgia skilled nursing facilities","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase agreements cover Glen Eagle (101 beds), Eastman (100 beds), Sparta (71 beds), and Warrenton (110 beds).","Aggregate purchase price $27.0M; $500k deposit placed into escrow with Landmark Abstract.","Closing expected by May 1, 2025, subject to due diligence, regulatory approvals, and customary conditions.","Operations transfer agreements also executed to transition operations to buyer-affiliated operators."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183179,"accession_number":"0001493152-25-003346","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2025-01-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CFO James Creamer resigns; CEO Adam Desmond named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James Creamer resigned as CFO effective January 17, 2025, under a separation agreement.","CEO Adam Desmond will serve as Interim CFO until a permanent CFO is appointed.","Separation Agreement and Release filed as Exhibit 10.1 to the 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199767,"accession_number":"0001493152-24-049235","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-12-09T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Selectis Health appoints WithumSmith+Brown as new independent auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective Dec 4, 2024, Board and Audit Committee appointed WithumSmith+Brown, PC as independent registered public accounting firm.","Company had not consulted Withum prior to engagement on accounting principles or audit opinions.","No disclosure of any disagreement with predecessor auditor or any reportable events."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199766,"accession_number":"0001493152-24-047478","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-11-22T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Selectis Health's auditor Marcum LLP resigns; going concern opinion issued for 2022/2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP terminated as independent auditor effective November 20, 2024.","No disagreements or reportable events occurred during Marcum's tenure (appointed 2022).","Marcum's audit reports for fiscal years 2022 and 2023 included going concern explanatory paragraphs.","Company has not yet engaged a new independent registered public accounting firm.","Marcum LLP agreed with the disclosures via letter dated November 22, 2024 (Exhibit 16.1)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199765,"accession_number":"0001493152-24-039043","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health raises CEO salary to $250K; CEO waives $30K board stipend","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Adam Desmond's salary increased from $150,000 to $250,000 per annum, effective October 1, 2024.","Desmond agreed to forgo the $7,500 quarterly Board compensation stipend ($30,000/year).","Net annual increase in cash compensation is approximately $70,000 before other benefits.","Salary adjustment approved by the Board of Directors on October 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215781,"accession_number":"0001493152-24-034418","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-08-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Selectis Health appoints James Creamer as CFO, effective Aug 15, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Creamer appointed CFO effective Aug 15, 2024; base salary $180,000/year.","Creamer had served as Interim CEO since Dec 2023; now CFO role only? Not clarified.","Offer letter filed as Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215780,"accession_number":"0001493152-24-026955","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-07-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Andrew Sink resigns from Selectis Health Board effective June 30, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Sink resigned as director, effective June 30, 2024; resignation tendered June 24.","No immediate plans to fill the vacancy caused by Mr. Sink's resignation.","Resignation disclosed in Form 8-K filed July 11, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235203,"accession_number":"0001493152-24-025023","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-06-25T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Selectis Health sells Georgia skilled nursing facility for $6.75M, reduces debt","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold Archway Transitional Care Center 1 in Macon, GA for $6.75M; buyer was lessee since 2016.","Proceeds reduced short-term debt by $150k and current maturities by $4.48M; cash increased $1.59M.","Pro forma net income attributable to common: $317.9k (Q1 2024) and $2.35M (FY23), vs. actual losses.","Sale closed June 18, 2024; PSA originally filed May 8, 2024 as Exhibit to prior 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235202,"accession_number":"0001493152-24-018515","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Selectis Health signs definitive agreement to sell Archway nursing facility for $6.75M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Wholly-owned subsidiary Goodwill Hunting, LLC (seller) entered PSA to sell Archway Property in Macon, GA to Bibb County Holdings II, LLC for $6.75M.","Purchaser has 45-day due diligence period from May 1, 2024; may terminate for any reason and receive $50,000 deposit refund.","Closing expected about 15 days after inspection period ends, subject to satisfaction of conditions.","Proceeds expected to enhance balance sheet and allow further portfolio optimization; company retains 11 other facilities across AR, GA, OH, OK."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235201,"accession_number":"0001493152-24-018264","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Selectis Health subsidiary agrees to sell Archway Transitional Care Center for $6.75M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price of $6,750,000 for skilled nursing facility in Macon, GA.","Seller is wholly-owned subsidiary Goodwill Hunting LLC; buyer is Bibb County Holdings II LLC.","Sale subject to customary conditions; no assurance of closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235200,"accession_number":"0001493152-24-015664","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"Selectis Health secures $750K line of credit at 8.5% due April 2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered into Commercial Line of Credit Agreement and Note with Southern Bank for $750,000 principal limit.","Fixed interest rate of 8.50% per annum.","Maturity date of April 12, 2025.","Funds available for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253022,"accession_number":"0001493152-24-011175","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-03-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health appoints Adam Desmond as permanent CEO effective March 18, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board of Directors appointed Adam Desmond as Chief Executive Officer, effective March 18, 2024.","Desmond previously served as Interim CEO before this permanent appointment.","Compensation for Desmond remains unchanged from his interim role.","No other changes to executive roles or compensation were reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253021,"accession_number":"0001493152-24-011167","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-03-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Selectis Health Board approves standard Indemnity Agreement for directors and officers","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board approved form of Indemnity Agreement effective March 18, 2024, for all directors and officers.","Agreement provides mandatory indemnification and advancement of expenses to fullest extent under Utah law.","Company will maintain D&O insurance if Board deems it economically reasonable.","No specific officers or directors named; agreement is a blank template applicable to all.","Routine governance measure; no change in compensation or leadership for any individual."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253020,"accession_number":"0001493152-24-007578","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2024-02-22T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Selectis Health's sale of Georgia subsidiaries terminated by purchaser; company denies defaults","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Effective Feb 20, 2024, Purchaser terminated the Purchase & Sale and Operations Transfer Agreements for certain Georgia subsidiaries without consummation.","Purchaser claimed Events of Default under the agreements; Selectis Health categorically denies those claims.","Company intends to pursue all rights and remedies regarding the terminated transaction.","The sale was previously disclosed in a Form 8-K dated December 5, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270490,"accession_number":"0001493152-23-045968","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2023-12-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Selectis Health appoints Jim Creamer interim CFO, Clifford Neuman to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jim Creamer appointed Interim CFO effective Dec 18, 2023; annual salary $120,000.","Clifford Neuman rejoins board effective Jan 1, 2024; serves on audit, governance, compensation committees.","Creamer has 20 years public company CFO experience; Neuman previously served on board from 2014 to 2022.","Neuman continues as company's primary legal counsel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270489,"accession_number":"0001493152-23-043689","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2023-12-05T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Selectis Health agrees to sell four Georgia skilled nursing facilities for $31M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of Warrenton, Eastman, Glen Eagle, and Sparta facilities for $31M aggregate consideration.","Purchaser placed $250,000 initial deposit; additional $250,000 due after due diligence.","Transaction to close after 45-day due diligence and regulatory approvals, subject to conditions.","Company will retain Archway Transitional Care in GA plus facilities in AR, OH, and OK.","Interim CEO cites attractive valuation and enhanced balance sheet flexibility from sale."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270488,"accession_number":"0001493152-23-039476","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2023-11-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CEO Lance Baller resigns; board member Adam Desmond named Interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lance J. Baller resigned as CEO, acting principal financial officer, and director effective Nov 13, 2023 or earlier upon replacement.","Adam Desmond, current board member, appointed Interim CEO with base salary of $150,000/year, same as Baller.","Company continues search for a principal financial officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307602,"accession_number":"0001493152-23-019646","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health President and COO Christopher Barker resigns effective May 31 due to health issues","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christopher 'Randy' Barker resigned as President, COO, and board member effective May 31, 2023.","Resignation tendered on May 27, 2023 and attributed to health issues.","Company has not appointed a successor and has made no decision on replacement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326599,"accession_number":"0001493152-23-007424","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2023-03-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CFO Christine Lucus resigns effective April 5, 2023; CEO Lance Baller interim PFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christine Lucus resigned as CFO, effective April 5, 2023.","CEO Lance Baller will serve as principal financial officer until a permanent CFO is named.","Company engaged an outside accounting firm to assist with financial reporting and accounting functions.","Resignation was tendered on March 6, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344311,"accession_number":"0001493152-22-034918","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-12-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Selectis Health annual meeting elects Andy Sink as Class I director, ratifies Marcum LLP as auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Andy Sink elected as Class I director with 1,270,541 For, 41,080 Withheld, and 209,377 broker non-votes.","Marcum LLP ratified as independent auditor for fiscal 2022 with 1,514,159 For, 6,725 Against, 114 Abstain.","A quorum of 1,520,998 shares (49.6% of outstanding) was present at the December 7, 2022 meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344310,"accession_number":"0001493152-22-032562","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-11-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Selectis Health presents at Rocky Mountain MicroCap Conference on Nov 10, 2022","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor presentation furnished as Exhibit 99.1; no specific financial results disclosed in the filing.","Company participated in the Rocky Mountain MicroCap Conference on November 10, 2022.","Regulation FD disclosure; information in the presentation is furnished, not filed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344309,"accession_number":"0001493152-22-030033","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-10-31T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health appoints Mary Christine Lucus as Secretary, replacing Clifford Neuman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mary Christine Lucus appointed as Secretary effective October 31, 2022.","She replaces Clifford Neuman; Ms. Lucus continues as CFO.","No other changes to executive leadership or compensation disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344308,"accession_number":"0001493152-22-029593","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Selectis Health presents at LD Micro Main Event; no material financial updates in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company presented its October 25, 2022 investor presentation at the LD Micro Main Event Conference VIII.","No new financial results, guidance, or material business developments disclosed in the filing.","Presentation furnished as Exhibit 99.1 but not incorporated by reference; no content details provided in this 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344307,"accession_number":"0001493152-22-029208","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-10-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Selectis Health appoints Andrew Sink to board; Clifford Neuman resigns as director and secretary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Sink appointed independent director effective Oct 17, 2022, filling vacancy from Clifford Neuman's resignation.","Appointment fulfills remaining corporate governance requirements for a major national exchange listing.","Sink brings 30+ years real estate experience; co-founder of Own Alabama LLC and managing director at Colliers International.","Clifford Neuman resigned as director and secretary concurrently with Sink's appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344306,"accession_number":"0001493152-22-028618","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-10-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Clifford Neuman resigns; Andrew Sink appointed to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Effective Oct 17, 2022, Clifford Neuman resigned as director and secretary of Selectis Health.","Andrew Sink appointed to fill the vacancy as Class I director, standing for reelection at Dec 2022 annual meeting.","Sink is co-founder of Own Alabama, managing director at Colliers International; 30+ years real estate experience.","He has been involved in transactions aggregating over $700M and managed funds over $100M.","Sink will serve on the Audit, Compensation, and Nominating & Governance committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344305,"accession_number":"0001493152-22-027649","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-10-05T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Selectis Health appoints Marcum LLP as new auditor, replacing Haynie & Company","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Former auditor Haynie & Company dismissed; no accounting disagreements, only previously reported material weaknesses.","Marcum LLP engaged effective October 4, 2022, for its senior healthcare industry expertise and timely filing capabilities.","Marcum LLP is a top-100 accounting firm with over $1B revenue and 3,400 associates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360822,"accession_number":"0001493152-22-026352","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-09-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Selectis Health Q2 revenue up 91% to $11.5M; net income $1.0M vs loss year ago","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2022 revenue $11.5M (record), up 91% YoY; net income $1.0M ($0.34 per share) vs net loss of $0.7M.","Q1 2022 revenue $10.1M, up 75% YoY; net income $0.2M ($0.07 per share) vs $0.2M.","Company became current on SEC filings by filing Q1 and Q2 2022 10-Qs, resolving prior delays.","Appointed Christine Lucus as CFO and David Furstenberg to board; cash $3.9M at June 30, 2022.","Operating cash flow improved to $0.1M for six months ended June 30, 2022 vs ($0.6M) year ago."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360821,"accession_number":"0001493152-22-023453","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-08-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health board committee member Clifford Neuman resigns from Audit, Compensation, and Nomination committees","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Clifford Neuman resigned from the Audit, Compensation, and Nomination and Governance Committees effective August 18, 2022.","No immediate plans to fill the vacancies created by Mr. Neuman's resignations from those committees.","Mr. Neuman will continue to serve as a member of the Board of Directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360820,"accession_number":"0001493152-22-020598","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-07-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Selectis Health adopts committee charters and appoints standing committee members","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board adopted Audit, Compensation, and Nominating & Governance Committee Charters on July 25, 2022.","Also adopted Code of Conduct, Document Retention, and Whistleblower policies the same day.","Audit Committee: David Furstenberg (Chairman, financial expert), Clifford Neuman, Adam Desmond.","Compensation Committee: Clifford Neuman (Chairman), David Furstenberg, Adam Desmond.","Nominating & Governance Committee: Adam Desmond (Chairman), David Furstenberg, Clifford Neuman."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360819,"accession_number":"0001493152-22-018471","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-07-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health appoints David J. Furstenberg to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointment effective July 1, 2022; Furstenberg will serve as a director.","He is a tax attorney and CPA; expected to serve on Audit Committee as financial expert.","Previously Director of Taxes at PulteGroup (1997-2016) and Handleman Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379937,"accession_number":"0001493152-22-008963","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-04-04T23:59:59+00:00","items":["3.02","5.02","9.01"],"status":"ready","headline":"Selectis Health grants 200,000 stock options to CEO and President/COO at $7.00","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Lance Baller and Randy Barker each received options for 100,000 shares at $7.00 exercise price.","Options are fully vested immediately upon grant (March 30, 2022) and expire in 10 years.","Options include cashless exercise provision; no fees or commissions paid in connection with grant.","Exhibit 10.2 names President as Christopher Barker, consistent with filing's Randy Barker reference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398099,"accession_number":"0001493152-22-006350","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-03-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Selectis Health CFO Brandon Thall resigns; Controller Christine Lucus named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brandon Thall resigned as CFO effective March 4, 2022; immediate departure.","Christine Lucus, former Controller, appointed interim CFO effective March 4, 2022.","Lucus base salary $135,000/year; eligible for $15,000 bonus for timely SEC filings.","Lucus previously Controller at Neubase Therapeutics (NASDAQ) and has 7 years experience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398098,"accession_number":"0001493152-22-002447","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-01-28T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Selectis Health dismisses MaloneBailey as auditor, appoints Haynie & Company","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved auditor change effective Jan 26, 2022; MaloneBailey dismissed, Haynie & Company engaged.","No disagreements with MaloneBailey on accounting principles or audit scope; no reportable events besides prior material weaknesses.","MaloneBailey's 2019 report included going concern emphasis; 2020 report unmodified.","Haynie & Company chosen for industry experience, firm size, and local presence; will also perform tax preparation.","Former auditor furnished letter (Exhibit 16) confirming agreement with disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398095,"accession_number":"0001493152-22-001919","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K/A","filed_at":"2022-01-21T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Selectis Health converts $795K of 11% Notes to 159K shares to boost net equity above $4M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Converted additional $165K in 11% Senior Secured Notes for 33K shares at $5/share on Jan 17, 2022.","Total Exchange Offering: $795K principal exchanged for 159K shares issued to 15 Note holders.","Exchange intended to increase net equity above $4M to support exchange listing approval.","Paid $8,200 solicitation fee to GVC Capital for converting client-held Notes.","Shares issued as restricted securities under Section 4(a)(2) exemption from registration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398097,"accession_number":"0001493152-22-000972","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-01-12T23:59:59+00:00","items":["3.02","8.01","9.01"],"status":"ready","headline":"Selectis Health grants 30,000-share option at $6.00 to Gateway Group for IR; $6,000 monthly fee","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Option to purchase 30,000 shares at $6.00 per share, fully vested, exercisable for 3 years with cashless exercise provision.","Granted to Gateway Group as compensation under a 12-month Financial Public Investor Relations Agreement; $6,000 monthly fee.","Sale of option was unregistered, relying on exemption under Section 4(2) of Securities Act.","Agreement initial term 12 months; automatically renews monthly unless terminated by either party."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398096,"accession_number":"0001493152-22-000724","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2022-01-10T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Selectis Health exchanges $640K debt for 128K shares at $5/share to boost equity for listing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchanged $640K principal of 2018 11% Senior Secured Promissory Notes for 128K common shares at $5.00/share.","Transaction effective Dec 31, 2021; completed Jan 6, 2022; involved 13 note holders.","Paid $6,100 solicitation fee to GVC Capital LLC for conversions by its clients.","Exchange intended to raise net equity above $4M to support exchange listing application."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398094,"accession_number":"0001493152-22-000029","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K/A","filed_at":"2022-01-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Selectis Health rescinds RSU grants to CEO Lance Baller and officer Randy Barker","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Rescission of Restricted Stock Units granted under the 2021 Deferred Compensation and Equity Award Plan.","Grants were originally announced on December 30, 2021, and rescinded after further consideration.","Officers involved are CEO Lance Baller and Randy Barker; a rescission agreement was executed.","No financial impact or reason for rescission disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":417097,"accession_number":"0001493152-21-032876","cik":727346,"company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","form_type":"8-K","filed_at":"2021-12-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Selectis Health grants 60,000 RSUs each to CEO and President/COO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Lance Baller and President/COO Randy Barker each granted 60,000 RSUs.","RSUs fully vested upon grant; each settles for one share of common stock.","Grants issued under the Company's 2021 Deferred Compensation and Equity Award Plan.","RSUs confer no voting rights or dividend participation until settlement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":9458809.717171717,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2021-12-30T23:59:59+00:00|417097"}